
Keywords: biomarker; cathelicidin; doxycycline; kallikrein; matrix metalloproteinase; papulopustular; rosacea; serine protease; AE; adverse event; BCA; bicinchoninic acid assay; CAMP; cathelicidin antimicrobial peptide; cDNA; complementary DNA; GAPDH; glyceraldehyd